An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
Clinical trial NCT01206816 · COMPLETED
Trial details
- NCT number
- NCT01206816
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-04
- Primary completion
- 2012-11-15
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.